Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2000 Dec;46:2383.

Response

Bruno Toussaint
PMCID: PMC2145005

Full text

PDF

Page 2383

2383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley C. M., Jr, Tollefson G., Tran P., Satterlee W., Sanger T., Hamilton S. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology. 1996 Feb;14(2):111–123. doi: 10.1016/0893-133X(95)00069-P. [DOI] [PubMed] [Google Scholar]
  2. Deshauer D., Albuquerque J., Alda M., Grof P. Seizures caused by possible interaction between olanzapine and clomipramine. J Clin Psychopharmacol. 2000 Apr;20(2):283–284. doi: 10.1097/00004714-200004000-00034. [DOI] [PubMed] [Google Scholar]
  3. Tollefson G. D., Beasley C. M., Jr, Tran P. V., Street J. S., Krueger J. A., Tamura R. N., Graffeo K. A., Thieme M. E. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997 Apr;154(4):457–465. doi: 10.1176/ajp.154.4.457. [DOI] [PubMed] [Google Scholar]
  4. Tollefson G. D., Sanger T. M., Lu Y., Thieme M. E. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry. 1998 Mar;55(3):250–258. doi: 10.1001/archpsyc.55.3.250. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES